Early Intervention Strategies for Lung Cancer

Launched by THE FIRST AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIVERSITY · May 23, 2025

Keywords

ClinConnect Summary

This clinical trial, titled "Early Intervention Strategies for Lung Cancer," is focused on finding out how effective and cost-efficient low-dose CT (LDCT) scans are for detecting lung cancer early. By using these scans, the study aims to see if we can find and treat lung cancer sooner, which could help reduce the number of people getting lung cancer and the number of deaths from it. The trial will take place in different community health service centers in Guangzhou, where researchers will gather data to understand the impact of these scans.

To participate, individuals must be aged 40 to 75, live in the community where the study is happening, and have no history of lung cancer or recent lung cancer screenings. They should be willing to sign consent forms and participate in follow-up checks. People who already have lung cancer, have serious health issues that prevent them from taking a CT scan, or are part of other studies that might interfere with this one will not be eligible. If you join, you can expect to undergo a low-dose CT scan, and your health will be monitored over time to see how well this screening strategy works.

Gender

ALL

Eligibility criteria

• • 1.Community Health Service Centers (Cluster Level)
• • 1. Inclusion Criteria The community health service center must be located within one of the 11 districts of Guangzhou.
• • The center must manage a population of over 10,000 elderly individuals. The center should be equipped with at least one CT machine and have qualified medical personnel, such as radiologists, radiologic technicians, and nursing staff.
• • 2. Exclusion Criteria Community health centers currently participating in other public health projects or studies that may affect screening results.
• • Community health service centers where researchers cannot collect data or conduct follow-up.
• • 2. Screening Subjects (Individual Level)
• • 1. Inclusion Criteria Aged 40-75 years. Residing in the community participating in the study for a long time. No known history of lung cancer and has not undergone lung cancer screening in the past three months.
• • Able to understand and willing to sign the informed consent form, and able to participate in long-term follow-up.
• • 2. Exclusion Criteria Individuals diagnosed with lung cancer. Individuals with severe other health issues that make them unsuitable for CT imaging.
• • Individuals unable to understand the study protocol or who cannot provide informed consent due to cognitive impairments.
• • Individuals participating in other clinical trials that may affect the results of this study.
• • Individuals unable to undergo follow-up.